| Title: |
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes |
| Authors: |
Marwaha, Ashish K; Chow, Samuel; Pesenacker, Anne M; Cook, Laura; Sun, Annika; Long, S Alice; Yang, Jennie H M; Ward-Hartstonge, Kirsten A; Williams, Evangelia; Domingo-Vila, Clara; Halani, Khalif; Harris, Kristina M; Tree, Timothy I M; Levings, Megan K; Elliott, Thomas; Tan, Rusung; Dutz, Jan P |
| Contributors: |
JDRF Canadian Clinical Trials Network; BC Children’s Hospital Research Institute; Immune Tolerance Network; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Diabetes UK; Innovative Medicines Initiative; European Union’s Horizon; Leona M. and Harry B. Helmsley Charitable Trust; National Institute for Health Research; Guy’s and St Thomas’ NHS Foundation Trust |
| Source: |
Immunotherapy Advances ; volume 2, issue 1 ; ISSN 2732-4303 |
| Publisher Information: |
Oxford University Press (OUP) |
| Publication Year: |
2021 |
| Description: |
Summary Objectives We assessed the safety of ustekinumab (a monoclonal antibody used in psoriasis to target the IL-12 and IL-23 pathways) in a small cohort of recent-onset ( |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/immadv/ltab022 |
| DOI: |
10.1093/immadv/ltab022/41556683/ltab022.pdf |
| Availability: |
https://doi.org/10.1093/immadv/ltab022; https://academic.oup.com/immunotherapyadv/advance-article-pdf/doi/10.1093/immadv/ltab022/41556683/ltab022.pdf; https://academic.oup.com/immunotherapyadv/article-pdf/2/1/ltab022/44157679/ltab022.pdf |
| Rights: |
https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.9B05169A |
| Database: |
BASE |